Publication | Closed Access

Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model

NanomedicineTumor ImmunologyMedicineImmunologyTlr-4 Agonist ResultsTherapeutic VaccineTumor TargetingImmunotherapyPharmacologyMouse ModelTumor Microenvironment